Dalpiciclib and pyrotinib in women with HER2-positive advanced breast cancer: a single-arm phase II trial.
Yan M, Niu L, Lv H, Zhang M, Wang J, Liu Z, Chen X, Lu Z, Zhang C, Zeng H, Zhao S, Feng Y, Sun H, Li H.
Yan M, et al. Among authors: zhao s.
Nat Commun. 2023 Oct 7;14(1):6272. doi: 10.1038/s41467-023-41955-7.
Nat Commun. 2023.
PMID: 37805496
Free PMC article.
Clinical Trial.